EUVIMEDEUVIMED entdecken
Crossref

Weighing Dose‐Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus

Brian Meng-Hsun Li iD, Jia-Horung Hung, Po-Cheng Yang, Swu-Jane Lin, Edward Chia-Cheng Lai iD, Meng-Yu Weng iD

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Brian Meng-Hsun Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Hydroxychloroquine, Lupus Erythematosus, Systemic, Antirheumatic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Science and Technology Council of Taiwan, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective To weigh higher‐dose hydroxychloroquine (HCQ; ≥400 mg/day) and lower‐dose HCQ (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxychloroquineLupus Erythematosus, SystemicAntirheumatic AgentsHumansFemaleMaleMiddle AgedAdultTaiwanRetinal DiseasesCoronary Artery DiseaseDose-Response Relationship, DrugVenous ThromboembolismRisk AssessmentNeoplasmsIschemic StrokeKidney Failure, ChronicAgedYoung Adult

Substanzen

HydroxychloroquineAntirheumatic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Population Health Data Center, National Cheng Kung University, Tainan, Taiwan.
  • Spencer Center for Vision Research, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California.
  • Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • School of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago.

ORCID-Profile: Brian Meng-Hsun Li, Edward Chia-Cheng Lai, Meng-Yu Weng

Förderung

  • National Science and Technology Council of Taiwan
  • National Science and Technology Council

Zitieren

APA

Li, B. M., Hung, J. H., Yang, P. C., Lin, S. J., Lai, E. C., & Weng, M. Y. (2026). Weighing Dose‐Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus. Arthritis & Rheumatology. https://doi.org/10.1002/art.70022

Vancouver

Li BM, Hung JH, Yang PC, Lin SJ, Lai EC, Weng MY. Weighing Dose‐Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus. Arthritis & Rheumatology. 2026. doi:10.1002/art.70022

BibTeX
@article{Li2026,
  author = {Li, Brian Meng-Hsun and Hung, Jia-Horung and Yang, Po-Cheng and Lin, Swu-Jane and Lai, Edward Chia-Cheng and Weng, Meng-Yu},
  title = {Weighing Dose‐Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70022}
}
Kostenlos starten →